Allicin acts over lipid metabolism and insulin resistance by increasing the AMP-activated protein kinase (AMPK) phosphorylation and decreasing the expression of sterol regulatory element binding protein 1 (SREBP-1) and SREBP-226 [44]. The gene discussed is SREBF1; the disease is Insulin resistance.